CHD
54
4
UAL
83
-2
NWSA
62
-7
HAS
30
-2
AA
56
15
CVS
41
-4
HRB
59
2
BEN
50
9
LRCX
37
-9
JWN
48
-2
RL
69
-4
GOOG
57
-6
F
56
-3
MCD
52
-5
DE
42
3
MSFT
48
-9
HAL
48
-3
SCHW
62
-2
CCI
30
-11
JBHT
56
-3
CHD
54
4
UAL
83
-2
NWSA
62
-7
HAS
30
-2
AA
56
15
CVS
41
-4
HRB
59
2
BEN
50
9
LRCX
37
-9
JWN
48
-2
RL
69
-4
GOOG
57
-6
F
56
-3
MCD
52
-5
DE
42
3
MSFT
48
-9
HAL
48
-3
SCHW
62
-2
CCI
30
-11
JBHT
56
-3
Financhill
Back

Shuttle Pharmaceuticals Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
18

SHPH
Shuttle Pharmaceuticals Holdings

Last Price:
0.98
Seasonality Move:
-10.89%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
18
Shuttle Pharmaceuticals Holdings (SHPH) is a Sell

Is Shuttle Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Shuttle Pharmaceuticals Holdings [SHPH] share price is $1.00. The Score for SHPH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • SHPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SHPH Stock Price Chart

What is Shuttle Pharmaceuticals Holdings's stock price today?

  • The Shuttle Pharmaceuticals Holdings share price today is $1.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SHPH is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SHPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 35.05 Sell
Chaikin Money Flow: -50670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.08 - 1.54) Sell
Bollinger Bands (100): (1.22 - 2.94) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SHPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.13 Sell
20-day SMA: 1.35 Sell
50-day SMA: 1.35 Sell
200-day SMA: 2.71 Sell
8-day EMA: 1.16 Sell
20-day EMA: 1.27 Sell
50-day EMA: 1.49 Sell
200-day EMA: 3.34 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Shuttle Pharmaceuticals Holdings Earnings Growth & SHPH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Shuttle Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):